McDonald’s is changing its menu for the Ozempic era

McDonald’s is trying to step into the Ozempic era. As part of an $8.5 billion overhaul of the restaurants planned over the next decade, the fast food giant is planning to meet customers amid a new era of eating habits. According to data from Gallup, around 11% of the US population is currently using a GLP-1 medication for weight loss purposes. Due to the rapid effects of the medication, those using drugs like Ozempic or Mounjaro need to prioritize protein intake to prevent muscle loss—a habit that has since led to a boom in protein-packed products. And now, McDonald’s is looking to jump on board with the protein craze, McDonald’s executives announced during the company’s investor day in Chicago on Sept. 23. The plan announced is set to roll out new menu items across various markets, including new wraps and grilled chicken sandwiches. Additionally, the new menu items may include bowls and egg bites, providing customers with high protein options at various sizes. “This is an opportunity. We need to keep giving them more reasons to make McDonald’s their first choice,” Skye Anderson, the president of McDonald’s USA, said during the investor day event. In addition to tapping into a gro…